These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20930005)

  • 1. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV₁ and diffusing capacity of the lung for carbon monoxide < 40%.
    Puente-Maestú L; Villar F; González-Casurrán G; Moreno N; Martínez Y; Simón C; Peñalver R; González-Aragoneses F
    Chest; 2011 Jun; 139(6):1430-1438. PubMed ID: 20930005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise.
    Wang JS; Abboud RT; Wang LM
    Chest; 2006 Apr; 129(4):863-72. PubMed ID: 16608931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of expiratory volume, diffusion capacity, and exercise tolerance following major lung resection: a prospective follow-up analysis.
    Brunelli A; Xiumé F; Refai M; Salati M; Marasco R; Sciarra V; Sabbatini A
    Chest; 2007 Jan; 131(1):141-7. PubMed ID: 17218568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).
    Colice GL; Shafazand S; Griffin JP; Keenan R; Bolliger CT;
    Chest; 2007 Sep; 132(3 Suppl):161S-77S. PubMed ID: 17873167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lung scintigraphy and ergospirometry in prediction of postoperative course in lung resection candidates with increased risk of postoperative complications].
    Bolliger CT; Wyser C; Roser H; Stulz P; Solèr M; Perruchoud AP
    Pneumologie; 1996 May; 50(5):334-41. PubMed ID: 8710817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise capacity assessment in patients undergoing lung resection.
    Bobbio A; Chetta A; Internullo E; Ampollini L; Carbognani P; Bettati S; Rusca M; Olivieri D
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):419-22. PubMed ID: 19138529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative pulmonary function as a predictor of respiratory complications and mortality in patients undergoing lung cancer resection.
    Fujiu K; Kanno R; Suzuki H; Shio Y; Higuchi M; Ohsugi J; Oishi A; Gotoh M
    Fukushima J Med Sci; 2003 Dec; 49(2):117-27. PubMed ID: 15065638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer.
    Ferguson MK; Watson S; Johnson E; Vigneswaran WT
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):660-4. PubMed ID: 24052607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Aug; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiologic evaluation of patients with lung cancer being considered for resectional surgery.
    Beckles MA; Spiro SG; Colice GL; Rudd RM;
    Chest; 2003 Jan; 123(1 Suppl):105S-114S. PubMed ID: 12527570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
    Ferguson MK; Vigneswaran WT
    Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.
    Eguchi T; Bains S; Lee MC; Tan KS; Hristov B; Buitrago DH; Bains MS; Downey RJ; Huang J; Isbell JM; Park BJ; Rusch VW; Jones DR; Adusumilli PS
    J Clin Oncol; 2017 Jan; 35(3):281-290. PubMed ID: 28095268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods.
    Brunelli A; Refai M; Salati M; Xiumé F; Sabbatini A
    Ann Thorac Surg; 2007 Mar; 83(3):1134-9. PubMed ID: 17307474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer.
    Greillier L; Thomas P; Loundou A; Doddoli C; Badier M; Auquier P; Barlési F
    Clin Lung Cancer; 2007 Nov; 8(9):554-61. PubMed ID: 18186960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
    Takeda S; Funakoshi Y; Kadota Y; Koma M; Maeda H; Kawamura S; Matsubara Y
    Ann Thorac Surg; 2006 Jul; 82(1):232-6. PubMed ID: 16798220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
    Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.
    Berry MF; Yang CJ; Hartwig MG; Tong BC; Harpole DH; D'Amico TA; Onaitis MW
    Ann Thorac Surg; 2015 Jul; 100(1):271-6. PubMed ID: 25986099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.
    Burt BM; Kosinski AS; Shrager JB; Onaitis MW; Weigel T
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):19-28, dicussion 28-29.e1. PubMed ID: 24766848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.